Solange Peters
University Hospital of Lausanne(CH)Swiss Paediatric Oncology Group(CH)Hôpital Orthopédique de la Suisse Romande(CH)Swiss Cancer Center Léman(CH)University of Pennsylvania(US)Stanford University(US)University of Lausanne(CH)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic(2018)2,846 cited
- → Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer(2019)2,789 cited
- → Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(2016)2,632 cited
- → First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer(2017)2,557 cited
- → Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer(2017)2,414 cited
- → Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(2017)2,321 cited